With Jim Thomas, CEO, Just Biotherapeutics
Jim Thomas, CEO of Just Biotherapeutics, entered the biopharma industry in the 1980s and has seen it all – from roller bottles to single-use. Reflecting on the past makes him confident that the industry will continue to improve. In this article he looks back over his career of 35 years in the industry and the challenges we have overcome. While there will be challenges in the future as well, he believes the sooner and more aggressively we face these challenges, the more quickly an inevitable future state, with substantially greater global access to biologic therapies, will be the present.